The clean beat across all segments and the credit facility expansion signal strong underlying momentum and financial flexibility. Look for potential M&A or accelerated share repurchases as the company deploys its expanded borrowing capacity. The lack of explicit forward guidance is a minor uncertainty, but the trajectory remains positive.
Price Chart
Executive Summary
Balchem Corporation reported Q2 2026 adjusted EPS of $1.49 on revenue of $284.0M, beating consensus estimates of $1.43 and $268.5M by 4.2% and 5.8%, respectively. Revenue grew 11.2% YoY with record performance across all three segments, and the company generated $46.7M in operating cash flow. The company also amended its credit facility to $650M and repurchased $29M in stock during the quarter.
Key Financial Metrics
Key Facts
- Q2 2026 adjusted EPS $1.49 vs consensus $1.43 (beat +4.2%)
- Q2 2026 revenue $284.0M vs consensus $268.5M (beat +5.8%)
- Revenue grew 11.2% YoY to $284.0M
- GAAP EPS $1.39 vs $1.17 YoY (+18.8%)
- Adjusted EBITDA $77.9M, +12.6% YoY
- Operating cash flow $46.7M, free cash flow $36.2M
- All three segments delivered record or near-record quarterly sales and earnings
- Credit facility amended: increased to $650M, extended to 2031
- Repurchased $29M of stock in Q2, $114M trailing twelve months
- Net debt leverage ratio of 0.3x
Financial Impact
Revenue beat by $15.5M (+5.8%) and EPS beat by $0.06 (+4.2%) with strong YoY growth, supported by broad-based segment strength and improved margins.
Risk Factors
- Higher manufacturing input costs and compensation-related expenses may pressure margins
- No explicit forward guidance provided, leaving room for uncertainty
- Stock buyback pace may slow if acquisition opportunities arise
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3336723 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 3d ago | 8-K | $175.49 | awaiting T+20 | — | $177.00 (+0.86%) |
Oct 23, 2026 3d ago | Press Release | $175.49 | awaiting T+20 | — | $177.00 (+0.86%) |
Jul 31, 2026 12w ago | 8-K | $167.56 $178.44 | ▲ +6.50% | ▲ +3.51% | $177.00 (+5.64%) |
Jul 31, 2026 12w ago | Press Release | $167.56 $178.44 | ▲ +6.50% | ▲ +3.51% | $177.00 (+5.64%) |
Jul 24, 2026 13w ago | 8-K | $164.79 $177.50 | ▲ +7.71% | ▲ +4.41% | $177.00 (+7.41%) |
Jul 17, 2026 14w ago | Press Release | $163.35 $178.51 | ▲ +9.28% | ▲ +4.83% | $177.00 (+8.36%) |
May 20, 2026 22w ago | Court Ruling | $161.75 $165.57 | ▲ +2.36% | ▲ +2.14% | $177.00 (+9.43%) |
Apr 16, 2026 27w ago | Press Release | $174.45 | awaiting T+20 | — | $177.00 (+1.46%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers